Agios Pharma (AGIO) PT Raised to $83 at Oppenheimer on 2Q Report; 'Strong Clinical Update'
Tweet Send to a Friend
Oppenheimer raised its price target on Agios Pharma (NASDAQ: AGIO) to $83.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
